Active Share (vs S&P 500): 91.2%
· vs QQQ: 92.5%
— share of the book that differs from index weights (higher = more active)
· ranking
In its Q3 2026 13F filing, FARALLON CAPITAL MANAGEMENT, L.L.C. disclosed 109 equity positions with a combined reported value of $22.58B. The filing implies a focused portfolio: its ten largest positions account for 62.3% of reported value. HoldingsHub classifies the profile as Large / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q3 2026 were SPY ($3.98B), RVMD ($2.75B), WBD ($1.53B). By sector, the heaviest allocations are Health Care 51.5%, Communication Services 9.6%. Versus the prior quarter, allocation shifted toward Communication Services (+6.3pp), Health Care (+3.3pp) and away from Other (-11.2pp).
Versus the prior quarter, FARALLON CAPITAL MANAGEMENT, L.L.C. opened 43 new positions, trimmed 19 and fully exited 23, a turnover rate of 64.4% of positions. The portfolio's overlap with the prior quarter was 50% of names.
The largest new positions opened in Q3 2026 were ROKU ($633.49M), CRH ($442.24M), IONI ($57.69M).
Of the 23 positions fully exited versus the prior quarter, the largest were EA ($1.62B), CRNX ($336.37M), APGE ($140.69M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
Latest Tom Steyer buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Farallon Capital Management is an SEC-registered 13F filer based in San Francisco, CA, United States. As of Q3 2026 it reported 109 US equity positions with a combined value of $22.58B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).
Regulatory AUM (Form ADV): $52.08B as of 2026-09-23
Client mix (by RAUM): pension and profit-sharing plans 100%
Manages 50 private funds, of which 50 hedge funds
Website: faralloncapital.com
Portfolio Structure
109 positions · $22.58B reported value (Q3 2026)
Top 10 holdings = 62.3% of reported value
Largest position: SPY (STATE STR SPDR S&P 500 ETF T) at 17.6%
Average position size: $207.17M
Sector Tilt
Health Care 51.5%
Communication Services 9.6%
Information Technology 6.8%
(classified holdings cover 82% of value)
Quarterly Activity
Q3 2026: 43 new, 23 added, 19 reduced, 23 exited
24 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
AI Rebalance Analysis
1. Overall direction and market view: The fund reduced exposure to large-cap passive ETF (SPY) and some mega-cap stocks (AMZN), while adding to healthcare and communication services stocks, suggesting a tilt toward active, high-growth sectors with potential upside.
2. Key moves:
- Reduced: SPY (by 13.0% shares), AMZN (by 10.0% shares), RVMD (by 1.0% shares).
- Added: WBD (+75.7% shares), NTRA (+17.2% shares), BBIO (+32.6% shares), PTGX (+1.4% shares), EXEL (+9.1% shares), ROIV (+52.0% shares).
- New: ROKU (new position).
3. Portfolio structure: Active, with a heavy bias toward healthcare (60% of top 10) and communication services; reduced passive exposure, indicating higher risk appetite for growth stocks.
4. Per-holding one-liner:
- SPY: S&P 500 ETF (unverified benchmark).
- RVMD: Cancer drug developer (Health Care).
- WBD: Media/entertainment conglomerate (Communication Services).
- NTRA: Genetic testing firm (Health Care).
- BBIO: Gene therapy developer (Health Care).
- PTGX: Autoimmune drug developer (Health Care).
- EXEL: Cancer drug developer (Health Care).
- ROIV: Biotech drug developer (Health Care).
- ROKU: Streaming TV platform (Communication Services).
- AMZN: E-commerce giant (Consumer Discretionary).
5. Style summary: Rotated from passive large-caps to concentrated healthcare and communication services bets, favoring high-growth biotech and media stocks.
Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 03:47
Every 13F share count is marked to the quarter-end close, rebuilding the NAV this
portfolio would have earned had it done nothing all quarter. This is a historical
reconstruction from already-public filings and prices — not a model forecast, so
precision/recall do not apply.
2025-Q2 = 100. Solid = reconstructed NAV, dashed = SPY benchmark.
Prices are split-adjusted closes and exclude dividends, so dividend-heavy
portfolios would in reality sit slightly above this line.
This portfolio is broadly diversified (Top-10 = 47.5% of reported value), so a
Top-10 proxy cannot represent the whole fund — only the full-holdings reconstruction is shown.
Why there is no forecast NAV
Not published because:
Top-10 covers < 85% of reported value · Holdings-forecast backtest F1 < 0.80 · Top-10 quarterly turnover > 20%
Source: full 13F positions marked to quarter-end closes (computed 2026-11-02 01:13:11).
Share counts and prices are used as a ratio, so splits cancel out.
Holdings Prediction Model
Predicts next-quarter Top-10 holdings and weights from the fund's own historical
trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative
volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through
quarter T. Weights are shares of the modelled portfolio.
The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.
Latest-Quarter Accuracy (2026-Q3)
P 70%R 70%F1 70%(modelled on 2026-Q2; 7/10 hit)
Low-confidence forecast
This fund replaces about 30% of its Top-10 each quarter and
backtests at F1 69% (threshold 80%).
Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.
SPY · RVMD · WBD · NTRA · BBIO · PTGX · EXEL · ROIV · ROKU · AMZN
★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.
Barra Factor Attribution
The disclosed long US equity book from the 2026-Q3 13F is held at its
report-date weights and decomposed over 2026-09-30 ~ 2026-11-16.
The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional
factor returns and an EWMA factor covariance for risk. The “portfolio” is the
visible 13F book, not the fund's true NAV.
The quarter is not complete yet; the window ends at the latest available price date, 2026-11-16, and will update as prices arrive.
Portfolio return-2.62%Buy & hold
QQQ synthetic benchmark-17.01%Liquidity weighted
Excess return+14.40%vs benchmark
Barra annualised vol21.3%Model estimate
Realised vol23.4%Annualised in window
Weighted beta1.02Raw exposure
Factor / specific risk69% / 31%Share of variance
Top-10 concentration69.5%Of reported value
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.
1. Performance
Metric
Value
Note
Portfolio return (buy & hold)
-2.62%
Disclosed long book
QQQ synthetic benchmark
-17.01%
Liquidity-weighted constituents
Model universe, equal weight
-1.70%
Opportunity-cost reference
Excess return
+14.40%
Portfolio − benchmark
Arithmetic return sum
-2.30%
Difference vs compounded is the cross term
Weighted raw beta
1.02
Weighted holding betas
Realised volatility (annualised)
23.40%
Daily returns in window
Barra model volatility (annualised)
21.34%
Factor + specific
Factor share of variance
68.8%
Barra factors
Specific share of variance
31.2%
Stock residuals
Reported value
$20.24B
13F long US equity
2. Return attribution
The -2.30% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.
Factor group
Factors
Contribution
Share of |return|
Size & Liquidity
6
-0.27%
-11.8%
Momentum & Growth
3
-3.70%
-160.6%
Volatility & Tail Risk
7
+3.02%
131.3%
Industry
12
+5.93%
257.4%
Specific
1
-7.28%
-316.3%
Factor
Type
Exposure
Factor return
Contribution
Share of |return|
Kurtosis
Style
+0.63
+7.51%
+4.71%
204.8%
Health Care
Industry
+0.52
+6.98%
+3.62%
157.1%
Other
Industry
+0.20
+8.78%
+1.73%
75.1%
Non-linear Size
Style
+1.38
+1.01%
+1.39%
60.5%
Communication Services
Industry
+0.11
+7.90%
+0.84%
36.6%
Leverage (Downside Vol)
Style
-0.48
-1.71%
+0.82%
35.5%
Beta
Style
+0.16
+4.44%
+0.72%
31.3%
Residual Volatility
Style
+0.21
+3.29%
+0.69%
30.1%
Growth
Style
+0.20
+1.75%
+0.35%
15.4%
Historical Volatility
Style
-0.02
-14.00%
+0.27%
11.8%
Consumer Discretionary
Industry
+0.03
+6.71%
+0.21%
9.0%
Liquidity
Style
+0.33
+0.36%
+0.12%
5.0%
Financials
Industry
+0.04
-2.80%
-0.10%
-4.5%
Short-term Reversal
Style
-0.15
+0.87%
-0.13%
-5.7%
Information Technology
Industry
+0.07
-5.13%
-0.37%
-16.1%
Size
Style
+0.21
-1.95%
-0.40%
-17.6%
Turnover
Style
+0.09
-4.80%
-0.41%
-18.0%
Mid Cap
Style
+0.23
-1.94%
-0.44%
-19.2%
Amihud Illiquidity
Style
+1.17
-0.45%
-0.52%
-22.6%
Max Drawdown
Style
+0.51
-1.76%
-0.91%
-39.3%
Skewness
Style
+0.75
-4.39%
-3.29%
-142.8%
Momentum
Style
+0.98
-4.00%
-3.92%
-170.3%
Specific
Specific
—
—
-7.28%
-316.3%
3. Risk attribution
Annualised volatility is 21.34%; factor risk explains 68.8% of variance and specific risk 31.2%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.
Factor
Type
Exposure
Share of variance
Vol contribution
Share of vol
Specific
Specific
—
31.2%
+6.65%
6.7%
Health Care
Industry
+0.52
21.6%
+4.61%
4.6%
Other
Industry
+0.20
13.7%
+2.92%
2.9%
Momentum
Style
+0.98
12.5%
+2.67%
2.7%
Beta
Style
+0.16
4.7%
+1.01%
1.0%
Amihud Illiquidity
Style
+1.17
3.2%
+0.68%
0.7%
Kurtosis
Style
+0.63
2.3%
+0.48%
0.5%
Information Technology
Industry
+0.07
2.1%
+0.45%
0.5%
Leverage (Downside Vol)
Style
-0.48
2.1%
+0.44%
0.4%
Liquidity
Style
+0.33
1.9%
+0.41%
0.4%
Residual Volatility
Style
+0.21
1.3%
+0.28%
0.3%
Max Drawdown
Style
+0.51
1.3%
+0.28%
0.3%
Growth
Style
+0.20
1.3%
+0.27%
0.3%
Communication Services
Industry
+0.11
1.2%
+0.26%
0.3%
Industrials
Industry
+0.04
1.2%
+0.25%
0.2%
Financials
Industry
+0.04
1.1%
+0.23%
0.2%
Consumer Discretionary
Industry
+0.03
1.0%
+0.21%
0.2%
Mid Cap
Style
+0.23
0.5%
+0.11%
0.1%
Short-term Reversal
Style
-0.15
-0.3%
-0.07%
-0.1%
Size
Style
+0.21
-0.8%
-0.18%
-0.2%
Skewness
Style
+0.75
-0.8%
-0.18%
-0.2%
Non-linear Size
Style
+1.38
-2.4%
-0.52%
-0.5%
4. Style exposures
Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.
Style factor
Portfolio
QQQ benchmark
Difference
Size
+0.21
+2.10
-1.89
Non-linear Size
+1.38
+1.68
-0.30
Mid Cap
+0.23
+0.13
+0.10
Beta
+0.16
+1.29
-1.13
Momentum
+0.98
+0.72
+0.26
Short-term Reversal
-0.15
-0.64
+0.49
Residual Volatility
+0.21
-0.40
+0.61
Historical Volatility
-0.02
+0.86
-0.88
Liquidity
+0.33
+0.11
+0.21
Amihud Illiquidity
+1.17
+1.16
+0.01
Turnover
+0.09
+0.21
-0.12
Growth
+0.20
+0.58
-0.38
Leverage (Downside Vol)
-0.48
+0.14
-0.62
Skewness
+0.75
+0.24
+0.51
Kurtosis
+0.63
+0.21
+0.41
Max Drawdown
+0.51
-0.08
+0.60
5. Industry allocation & Brinson
Sector
Portfolio
Benchmark
Portfolio ret
Benchmark ret
Allocation
Selection
Interaction
Total
Information Technology
7.2%
73.6%
-4.19%
-22.33%
+3.45%
+13.36%
-12.04%
+16.14%
Communication Services
10.7%
2.6%
+1.59%
-17.64%
-0.04%
+0.50%
+1.55%
+0.63%
Financials
3.7%
0.0%
+11.98%
+0.00%
+0.63%
+0.00%
+0.44%
+0.44%
Other
19.7%
0.0%
+2.16%
+0.00%
+3.37%
+0.00%
+0.42%
+0.42%
Utilities
0.0%
0.8%
+0.00%
+11.13%
-0.22%
-0.09%
+0.09%
-0.09%
Consumer Staples
0.0%
0.8%
+10.34%
+15.26%
-0.26%
-0.04%
+0.04%
-0.13%
Industrials
3.8%
11.1%
+7.35%
+4.36%
-1.58%
+0.33%
-0.22%
-0.21%
Consumer Discretionary
3.1%
8.8%
+2.88%
+3.76%
-1.20%
-0.08%
+0.05%
-0.24%
Health Care
51.8%
1.7%
-6.42%
+8.29%
+12.72%
-0.25%
-7.36%
-3.47%
Total
+16.78%
+13.65%
-16.97%
+13.46%
6. Holdings & contribution
Symbol
Name
Sector
Weight
Return
Contribution
QoQ
SPY
STATE STR SPDR S&P 500 ETF T
Other
19.67%
+2.16%
+0.42%
Reduce
RVMD
REVOLUTION MEDICINES INC
Health Care
13.61%
-18.70%
-2.54%
Reduce
WBD
WARNER BROS DISCOVERY INC
Communication Services
7.55%
+0.00%
+0.00%
Add
NTRA
NATERA INC
Health Care
5.31%
-30.20%
-1.60%
Add
BBIO
BRIDGEBIO PHARMA INC
Health Care
4.63%
+17.57%
+0.81%
Add
PTGX
PROTAGONIST THERAPEUTICS INC
Health Care
4.48%
-11.40%
-0.51%
Add
EXEL
EXELIXIS INC
Health Care
4.24%
+14.88%
+0.63%
Add
ROIV
ROIVANT SCIENCES LTD
Health Care
3.93%
+5.58%
+0.22%
Add
ROKU
ROKU INC
Communication Services
3.13%
+5.41%
+0.17%
New
AMZN
AMAZON COM INC
Consumer Discretionary
2.92%
+3.45%
+0.10%
Reduce
GRAL
GRAIL INC
Health Care
2.82%
-24.64%
-0.69%
Reduce
BSX
BOSTON SCIENTIFIC CORP
Health Care
2.43%
+0.09%
+0.00%
Add
AVGO
BROADCOM INC
Information Technology
2.42%
-5.07%
-0.12%
Add
CRH
CRH PLC
Industrials
2.19%
+11.56%
+0.25%
New
TWST
TWIST BIOSCIENCE CORP
Health Care
2.04%
-45.64%
-0.93%
Hold
UNH
UNITEDHEALTH GROUP INC
Health Care
1.90%
+12.24%
+0.23%
Reduce
MSFT
MICROSOFT CORP
Information Technology
1.86%
+0.99%
+0.02%
Reduce
SNPS
SYNOPSYS INC
Information Technology
1.84%
+1.47%
+0.03%
Add
KKR
KKR & CO INC
Financials
1.75%
+4.57%
+0.08%
Reduce
AON
AON PLC
Financials
1.70%
+23.97%
+0.41%
Reduce
Contribution rank
Symbol
Sector
Weight
Return
Contribution
1
LQDA
Health Care
1.33%
+86.29%
+1.15%
2
BBIO
Health Care
4.63%
+17.57%
+0.81%
3
EXEL
Health Care
4.24%
+14.88%
+0.63%
4
SPY
Other
19.67%
+2.16%
+0.42%
5
AON
Financials
1.70%
+23.97%
+0.41%
6
CRH
Industrials
2.19%
+11.56%
+0.25%
7
UNH
Health Care
1.90%
+12.24%
+0.23%
8
ROIV
Health Care
3.93%
+5.58%
+0.22%
9
PTGX
Health Care
4.48%
-11.40%
-0.51%
10
GRAL
Health Care
2.82%
-24.64%
-0.69%
11
TWST
Health Care
2.04%
-45.64%
-0.93%
12
NTRA
Health Care
5.31%
-30.20%
-1.60%
13
RVMD
Health Care
13.61%
-18.70%
-2.54%
7. Conclusions
Over the attribution window 2026-09-30 → 2026-11-16 (33 trading days), the reported portfolio returned -2.62%, versus -17.01% for the QQQ synthetic benchmark — an excess of +14.40%.
Return attribution: the largest positive style/industry contributions came from Kurtosis +4.71%, Health Care +3.62%, Other +1.73%; the largest drags came from Momentum -3.92%, Skewness -3.29%, Max Drawdown -0.91%. Specific (stock-level) return contributed -7.28%.
Risk attribution: Barra model volatility is 21.34% annualised; factor risk explains 69% of variance and specific risk 31%. The largest factor risk sources are Health Care 21.6%, Other 13.7%, Momentum 12.5%.
Style tilt: size +0.21, momentum +0.98, volatility -0.02, liquidity +0.33; the weighted raw beta is 1.02. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
Industry: the largest overweight versus the benchmark is Health Care (+50.0 pp), the largest underweight is Information Technology (-66.4 pp). Allocation contributed +16.78%, selection +13.65% and interaction -16.97%.
Concentration: the top-10 positions are 69.5% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.
FAQ
What did FARALLON CAPITAL MANAGEMENT, L.L.C. buy in 2026-Q3?
In its 2026-Q3 13F filing, FARALLON CAPITAL MANAGEMENT, L.L.C. reported 109 equity positions worth $22.58B in aggregate; its largest disclosed positions were SPY ($3.98B), RVMD ($2.75B), WBD ($1.53B).
How large is FARALLON CAPITAL MANAGEMENT, L.L.C.'s portfolio?
FARALLON CAPITAL MANAGEMENT, L.L.C. reported $22.58B of long equity holdings across 109 positions as of 2026-Q3. Top-10 holdings account for 62.3% of reported value.
What is FARALLON CAPITAL MANAGEMENT, L.L.C.'s investment style?
HoldingsHub classifies the portfolio as Large / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.
Embed this fund on your site
Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.
<iframe src="https://holdingshub.top/funds/farallon-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>